These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12795049)

  • 21. Pharmacology and clinical action of COX-2 selective NSAIDs.
    Bovill JG
    Adv Exp Med Biol; 2003; 523():201-14. PubMed ID: 15088852
    [No Abstract]   [Full Text] [Related]  

  • 22. COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors.
    Whittle BJ
    Gut; 2000 Sep; 47(3):320-5. PubMed ID: 10940262
    [No Abstract]   [Full Text] [Related]  

  • 23. Cyclooxygenase-2 and colorectal cancer.
    DuBois RN
    Prog Exp Tumor Res; 2003; 37():124-37. PubMed ID: 12795052
    [No Abstract]   [Full Text] [Related]  

  • 24. Cyclooxygenase-1 deletion enhances apoptosis but does not protect against ultraviolet light-induced tumors.
    Pentland AP; Scott G; VanBuskirk J; Tanck C; LaRossa G; Brouxhon S
    Cancer Res; 2004 Aug; 64(16):5587-91. PubMed ID: 15313895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Selective cyclooxygenase-2 inhibitor].
    Hettich M; Thomae K
    Internist (Berl); 1997 Oct; 38(10):1007. PubMed ID: 9432492
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterization of prostaglandin H synthase 2 deficient mice and implications for mechanisms of NSAID action.
    Morham SG; Langenbach R; Mahler J; Smithies O
    Adv Exp Med Biol; 1997; 407():131-8. PubMed ID: 9321943
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclooxygenase-2 in lung cancer.
    Dubinett SM; Sharma S; Huang M; Dohadwala M; Pold M; Mao JT
    Prog Exp Tumor Res; 2003; 37():138-62. PubMed ID: 12795053
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclooxygenase-2 inhibitors in cancer prevention and treatment.
    Masferrer JL
    Adv Exp Med Biol; 2003; 532():209-13. PubMed ID: 12908559
    [No Abstract]   [Full Text] [Related]  

  • 29. The regulation of cyclooxygenase-1 and -2 in knockout cells and cyclooxygenase and fever in knockout mice.
    Ballou LR
    Ernst Schering Res Found Workshop; 2000; (31):97-124. PubMed ID: 10943330
    [No Abstract]   [Full Text] [Related]  

  • 30. Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development.
    Bol DK; Rowley RB; Ho CP; Pilz B; Dell J; Swerdel M; Kiguchi K; Muga S; Klein R; Fischer SM
    Cancer Res; 2002 May; 62(9):2516-21. PubMed ID: 11980643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of cyclooxygenase-2 (COX-2) in breast cancer, and implications of COX-2 inhibition.
    Singh-Ranger G; Mokbel K
    Eur J Surg Oncol; 2002 Nov; 28(7):729-37. PubMed ID: 12431470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclooxygenase-2 inhibitors.
    Gajraj NM
    Anesth Analg; 2003 Jun; 96(6):1720-1738. PubMed ID: 12761004
    [No Abstract]   [Full Text] [Related]  

  • 33. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis.
    Tiano HF; Loftin CD; Akunda J; Lee CA; Spalding J; Sessoms A; Dunson DB; Rogan EG; Morham SG; Smart RC; Langenbach R
    Cancer Res; 2002 Jun; 62(12):3395-401. PubMed ID: 12067981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclooxygenase isoforms in human skin.
    Goldyne ME
    Prostaglandins Other Lipid Mediat; 2000 Nov; 63(1-2):15-23. PubMed ID: 11104338
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cyclo-oxygenase 2 inhibitors and cancer].
    André T; Soria JC
    Bull Cancer; 2004 May; 91 Spec No():S59-60. PubMed ID: 15239332
    [No Abstract]   [Full Text] [Related]  

  • 36. Cyclooxygenase-2 inhibitor therapy for the prevention of esophageal adenocarcinoma in Barrett's esophagus.
    Gupta RA; DuBois RN
    J Natl Cancer Inst; 2002 Mar; 94(6):406-7. PubMed ID: 11904306
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclooxygenase 2: from inflammation to carcinogenesis.
    Ristimäki A
    Novartis Found Symp; 2004; 256():215-21; discussion 221-6, 259-69. PubMed ID: 15027493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COX-2 inhibitors: background knowledge for clinical use. Summary.
    Katori M
    Inflamm Res; 1998 Oct; 47 Suppl 2():S117. PubMed ID: 9831334
    [No Abstract]   [Full Text] [Related]  

  • 39. Mouse skin as a model for cancer chemoprevention by nonsteroidal anti-inflammatory drugs.
    Marks F; Fürstenberger G; Neufang G; Müller-Decker K
    Recent Results Cancer Res; 2003; 163():46-57; discussion 264-6. PubMed ID: 12903842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors.
    Katori M; Majima M
    Inflamm Res; 2000 Aug; 49(8):367-92. PubMed ID: 11028754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.